Position: Full Professorship (W3) in “Translational pediatric sarcoma research”
Code number: 2019-0365
Together with the Faculty of Medicine at the University of Heidelberg, and supported by the Barbara und Wilfried Mohr-Stiftung, the German Cancer Research Center (DKFZ) is offering:
Full Professorship (W3) in
“Translational pediatric sarcoma research”
The focus of this professorship will be to establish an internationally competitive research program in the area of translational pediatric sarcoma in the context of the newly founded Hopp children’s comprehensive cancer center (KiTZ). The scientific focus will be on genetic, molecular and cell biological research of pediatric bone and soft tissue sarcomas. Main focus of the position is on Ewing sarcoma and/or Rhabdomyosarcoma. The future successful candidate will have outstanding knowledge in biological fundamentals in the development and progression of sarcoma as well as relevant experience in clinical practice. Therefore, we are looking for a clinician scientist, ideally with a specialist training in pathology.
We are looking for an outstanding personality, representing the field in research and teaching. Relevant experience in acquiring and carrying out third-party-funded projects and supervising scientific work are also expected. Ideally, the future candidate has scientific experience in several of the following areas: (molecular) pathology of these tumors, genetic analysis, establishment of predictive and prognostic markers, modeling, and clinical issues (e.g. therapy-resistance, tumor heterogeneity).
The position is associated with the leadership of a division in the research program “Functional and Structural Genomics” at the DKFZ.
The appointment requires a university degree, an excellent doctorate as well as a lecturer qualification (Habilitation), or a positively reviewed junior professorship or equivalent qualification (according to § 47 of the State of Baden-Württemberg University legislation (§ 47 LHG BW)). The successful candidate will be appointed as a full professor of the University of Heidelberg and will be granted leave of absence in order to be employed at the DKFZ according to the “Jülicher Modell”. In case all legal requirements are met, the candidate will be appointed with a permanent civil-servant status.
The German Cancer Research Center (DKFZ) and the University of Heidelberg seek to achieve a higher proportion of women in areas where they have not been adequately represented so far. Women with the requisite qualifications are expressly encouraged to apply.
Among candidates of equal aptitude and qualifications, applicants with disabilities will be given preference.
Applications, including a curriculum vitae incl. copies of diplomas and degrees, list of publications, and a research concept, should be sent until 26.12.2019 in electronic form to the Medical Faculty of Heidelberg, Im Neuenheimer Feld 672, 69120 Heidelberg, Germany, and through the DKFZ online application tool (www.dkfz.de/jobs) to Prof. Dr. Michael Baumann, Scientific Director of the German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Please follow the guidelines of the Medical Faculty at www.medizinische-fakultaet-hd.uni-heidelberg.de/professur.
- Interesting, versatile workplace
- International, attractive working environment
- Campus with modern state-of-the-art infrastructure
- Professor remuneration
- Flexible working hours
- Comprehensive further training program
Application Deadline: 26.12.2019
Prof. Dr. med. Michael Baumann
Phone +49 (0)6221/42-2850
Please note that we do not accept applications submitted via email.